BICO Group AB (publ) (STO:BICO)

Market Cap	1.55B -3.4%
Revenue (ttm)	1.50B -2.5%
Net Income	-839.20M
EPS	-11.89
Shares Out	70.57M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	175,738
Open	22.20
Previous Close	22.20
Day's Range	21.55 - 22.50
52-Week Range	12.94 - 25.42
Beta	2.54
Analysts	Hold
Price Target	29.00 (+32.12%)
Earnings Date	Aug 19, 2026

About BICO Group AB

BICO Group AB (publ) provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally. It operates through two segments: Life Science Solutions and Lab Automation. The Bioprinting segment offers 3D bioprinters and bioinks with a range of technologies for various applications, resolutions, and volume/speed requirements, as well as provides services focused on accelerating drug discovery and development. The Life Science Solutions segment supplies lab instrumentation, consumables and application...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2016
• Employees: 554
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BICO

Financial Performance

In 2025, BICO Group AB's revenue was 1.50 billion, a decrease of -13.32% compared to the previous year's 1.73 billion. Losses were -1.09 billion, 19698.2% more than in 2024.

Analyst Summary

According to one analyst, the rating for BICO stock is "Hold" and the 12-month stock price target is kr 29.00.

Price Target

kr 29.00

(32.12% upside)

Analyst Consensus: Hold

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 4, 2026

Data Sources Report a data error